NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer.
Bauman JE, Harris J, Uppaluri R, Yao M, Ferris RL, Chen J, Jordan RC, Joshi NP, Jujjuvaparu S, Blakaj DM, Henson C, Sheqwara J, Mell LK, Sen N, Clump DA, Garg MK, Yilmaz E, Torres-Saavedra P, Le QT.
Bauman JE, et al. Among authors: sheqwara j.
Cancers (Basel). 2021 Jun 9;13(12):2882. doi: 10.3390/cancers13122882.
Cancers (Basel). 2021.
PMID: 34207599
Free PMC article.